Patents by Inventor Giulio Paciotti

Giulio Paciotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8137989
    Abstract: In accordance with the present invention, a composition and method is provided that allows for the administration of a biologically-active factors to a human or animal. The present invention can be used to treat a disease with a biologically-active factor or combination of biologically-active factors, or can be used to safely vaccinate a human or animal against a biologically-active factor. It can also be used as a method for the delivery of biologically-active factors for the treatment of disease. Additionally, the present invention also includes a method of targeted drug delivery for the treatment of disease through the administration of custom complexes containing of one or more biologically active factors bound to a colloidal metal where at least one of the biologically-active factors is capable of binding a high affinity receptor on a cell surface.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: March 20, 2012
    Assignee: CytImmune Sciences, Inc.
    Inventors: Lawrence Tamarkin, Giulio Paciotti
  • Publication number: 20070231408
    Abstract: The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, these vector compositions comprise a colloidal metal, derivatized PEG (polyethylene glycol) and an agent. The invention also comprises methods and compositions for making such colloidal metal compositions and for treatment of cancer.
    Type: Application
    Filed: May 22, 2007
    Publication date: October 4, 2007
    Inventors: Lawrence Tamarkin, Giulio Paciotti
  • Publication number: 20070160572
    Abstract: The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, these vector compositions comprise a colloidal metal, derivatized PEG (polyethylene glycol) and an agent. The invention also comprises methods and compositions for making such colloidal metal compositions and for treatment of cancer.
    Type: Application
    Filed: September 6, 2006
    Publication date: July 12, 2007
    Inventors: Lawrence Tamarkin, Giulio Paciotti
  • Publication number: 20050175583
    Abstract: The present invention comprises compositions and methods for making monoclonal antibodies. The present invention further comprises vectors that replicate the immune system components, particularly an antigen-presenting cell (APC) element of the immune synapse. Additionally, the present invention may further comprise synthetic T-cells.
    Type: Application
    Filed: December 2, 2004
    Publication date: August 11, 2005
    Inventors: Lawrence Tamarkin, Giulio Paciotti
  • Publication number: 20050175584
    Abstract: The present invention comprises methods and compositions for making functionalized/reactive colloidal metal compositions and the uses thereof. The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and biological factors. In general, these vector compositions comprise a functionalized/reactive colloidal metal, and an agent. The invention also comprises methods and compositions for the treatment of cancer.
    Type: Application
    Filed: January 28, 2005
    Publication date: August 11, 2005
    Inventors: Giulio Paciotti, Lawrence Tamarkin